Atlas Arteria Group
OTC:MAQAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atlas Arteria Group
OTC:MAQAF
|
AU |
|
D
|
Deutsche Telekom AG
OTC:DTEGY
|
DE |
|
T
|
Textron Inc
BMV:TXT
|
US |
|
S
|
Schroder European Real Estate Investment Trust PLC
JSE:SCD
|
UK |
|
A
|
ACG Acquisition Company Ltd
LSE:ACG
|
VG |
|
C
|
CNA Financial Corp
SWB:CNH
|
US |
|
A
|
AJ Bell PLC
SWB:3FY
|
UK |
|
BCE Inc
TSX:BCE
|
CA |
|
P
|
Petroleo Brasileiro SA Petrobras
XMUN:PJXA
|
BR |
|
Republic Airways Holdings Inc
F:M2A0
|
US |
|
S
|
Springer Nature AG & Co KgaA
F:SPG
|
DE |
|
M
|
Myers Industries Inc
F:MJF
|
US |
|
Cellectis SA
PAR:ALCLS
|
FR |
|
Cipher Mining Inc
F:3A9
|
US |
|
Baozun Inc
F:2BZ
|
CN |
|
Oscar Health Inc
NYSE:OSCR
|
US |
Wall St Price Targets
MAQAF Price Targets Summary
Atlas Arteria Group
According to Wall Street analysts, the average 1-year price target for MAQAF is 3.24 USD with a low forecast of 2.81 USD and a high forecast of 3.76 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MAQAF's stock price target?
Price Target
3.24
USD
According to Wall Street analysts, the average 1-year price target for MAQAF is 3.24 USD with a low forecast of 2.81 USD and a high forecast of 3.76 USD.
What is the Revenue forecast for Atlas Arteria Group?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 5%.
What is the Net Income forecast for Atlas Arteria Group?
Projected CAGR
28%
The compound annual growth rate for Net Income over the next 3 years is 28%.
